The role of IFN-alpha; and nitric oxide in the release of HMGB1 by RAW 264.7 cells stimulated with polyinosinic-polycytidylic acid or lipopolysaccharide

Journal of Immunology

Volumn 177, Issue 5, 2006, Pages 3337-3343

  Jiang, Weiwen ^a   Pisetsky, David S ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; DOUBLE STRANDED RNA; HIGH MOBILITY GROUP B1 PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; JANUS KINASE; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRIC OXIDE; POLYCYTIDYLIC ACID; POLYINOSINIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BONE MARROW; CONTROLLED STUDY; DNA TRANSCRIPTION; ENZYME INHIBITION; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MEDIATOR RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN SECRETION; SHOCK;

EID: 33747794011     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.5.3337     Document Type: Article

References (50)

1. Agresti, A., R. Lupo, M. E. Bianchi, and S. Muller. 2003. HMGB1 interacts differentially with members of the Rel family of transcription factors. Biochem. Biophys. Res. Commun. 302: 421-426.
2. Banerjee, S., and T. K. Kundu. 2003. The acidic C-terminal domain and A-box of HMGB-1 regulates p53-mediated transcription. Nucleic Acids Res. 31: 3236-3247.
3. Falciola, L., F. Spada, S. Calogero, G. Langst, R. Voit, I. Grummt, and M. E. Bianchi. 1997. High mobility group 1 protein is not stably associated with the chromosomes of somatic cells. J. Cell Biol. 137: 19-26.
4. Wang, H., O. Bloom, M. Zhang, J. M. Vishnubhakat, M. Ombrellino, J. Che, A. Frazier, H. Yang, S. Ivanova, L. Borovikova, et al. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251.
5. Scaffidi, P., T. Misteli, and M. E. Bianchi. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195.
6. Wang, H., H. Yang, and K. J. Tracey. 2004. Extracellular role of HMGB1 in inflammation and sepsis. J. Intern. Med. 255: 320-331.
7. Bonaldi, T., F. Talamo, P. Scaffidi, D. Ferrera, A. Porto, A. Bachi, A. Rubartelli, A. Agresti, and M. E. Bianchi. 2003. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 22: 5551-5560.
8. Rendon-Mitchell, B., M. Ochani, J. Li, J. Han, H. Wang, H. Yang, S. Susarla, C. Czura, R. A. Mitchell, G. Chen, et al. 2003. IFN-γ induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J. Immunol. 170: 3890-3897.
9. Wang, H., J. M. Vishnubhakat, O. Bloom, M. Zhang, M. Ombrellino, A. Sama, and K. J. Tracey. 1999. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 126: 389-392.
10. Abraham, E., J. Arcaroli, A. Carmody, H. Wang, and K. J. Tracey. 2000. HMG-1 as a mediator of acute lung inflammation. J. Immunol. 165: 2950-2954.
11. Agnello, D., H. Wang, H. Yang, K. J. Tracey, and P. Ghezzi. 2002. HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine 18: 231-236.
12. Sappington, P. L., R. Yang, H. Yang, K. J. Tracey, R. L. Delude, and M. P. Fink. 2002. HMGB1 B box increases the permeability of Caco-2 enterocytic mono-layers and impairs intestinal barrier function in mice. Gastroenterology 123: 790-802.
13. Dumitriu, I. E., P. Baruah, M. E. Bianchi, A. A. Manfredi, and P. Rovere-Querini. 2005. Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells. Eur. J. Immunol. 35: 2184-2190.
14. Li, J., R. Kokkola, S. Tabibzadeh, R. Yang, M. Ochani, X. Qiang, H. E. Harris, C. J. Czura, H. Wang, L. Ulloa, et al. 2003. Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol. Med. 9: 37-45.
15. Yang, H., M. Ochani, J. Li, X. Qiang, M. Tanovic, H. E. Harris, S. M. Susarla, L. Ulloa, H. Wang, R. DiRaimo, et al. 2004. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. USA 101: 296-301.
16. Kokkola, R., J. Li, E. Sundberg, A. C. Aveberger, K. Palmblad, H. Yang, K. J. Tracey, U. Andersson, and H. E. Harris. 2003. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum. 48: 2052-2058.
17. Wang, H., H. Yang, C. J. Czura, A. E. Sama, and K. J. Tracey. 2001. HMGB1 as a late mediator of lethal systemic inflammation. Am. J. Respir. Crit. Care Med. 164: 1768-1773.
18. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
19. Jiang, W., J. Li, M. Gallowitsch-Puerta, K. J. Tracey, and D. S. Pisetsky. 2005. The effects of CpG DNA on HMGB1 release by murine macrophage cell lines. J. Leukocyte Biol. 78: 930-936.
20. Jiang, W., C. F. Reich III, and D. S. Pisetsky. 2004. Mechanisms of activation of the RAW264.7 macrophage cell line by transfected mammalian DNA. Cell. Immunol. 229: 31-40.
21. Chen, G., J. Li, M. Ochani, B. Rendon-Mitchell, X. Qiang, S. Susarla, L. Ulloa, H. Yang, S. Fan, S. M. Goyert, et al. 2004. Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms. J. Leukocyte Biol. 76: 994-1001.
22. Takeda, K., and S. Akira. 2004. TLR signaling pathways. Semin. Immunol. 16: 3-9.
23. Ajizian, S. J., B. K. English, and E. A. Meals. 1999. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and Interferon-γ. J. Infect. Dis. 179: 939-944.
24. Chan, E. D., and D. W. Riches. 1998. Potential role of the JNK/SAPK signal transduction pathway in the induction of iNOS by TNF-α. Biochem. Biophys. Res. Commun. 253: 790-796.
25. Rincon, M., H. Enslen, J. Raingeaud, M. Recht, T. Zapton, M. S. Su, L. A. Penix, R. J. Davis, and R. A. Flavell. 1998. Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 17: 2817-2829.
26. Sluss, H. K., T. Barrett, B. Derijard, and R. J. Davis. 1994. Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol. Cell. Biol. 14: 8376-8384.
27. Evans, T., A. Carpenter, H. Kinderman, and J. Cohen. 1993. Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ. Shock 41: 77-81.
28. Siegal, F. P., N. Kadowaki, M. Shodell, P. A. Fitzgerald-Bocarsly, K. Shah, S. Ho, S. Antonenko, and Y. J. Liu. 1999. The nature of the principal type 1 interferon-producing cells in human blood. Science 284: 1835-1837.
29. Takaoka, A., Y. Mitani, H. Suemori, M. Sato, T. Yokochi, S. Noguchi, N. Tanaka, and T. Taniguchi. 2000. Cross talk between interferon-γ and -αβ signaling components in caveolar membrane domains. Science 288: 2357-2360.
30. Mitani, Y., A. Takaoka, S. H. Kim, Y. Kato, T. Yokochi, N. Tanaka, and T. Taniguchi. 2001. Cross talk of the interferon-αβ signalling complex with gp130 for effective interleukin-6 signalling. Genes Cells 6: 631-640.
31. Levy, D. E., and J. E. Darnell, Jr. 2002. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3: 651-662.
32. Kadowaki, N., S. Antonenko, J. Y. Lau, and Y. J. Liu. 2000. Natural Interferon αβ-producing cells link innate and adaptive immunity. J. Exp. Med. 192: 219-226.
33. Svane, I. M., K. Nikolajsent, M. R. Walter, S. Buus, M. Gad, M. H. Claesson, and A. E. Pedersen. 2006. Characterization of monocyte-derived dendritic cells maturated with IFN-α. Scand. J. Immunol. 63: 217-222.
34. Kimura, M., L. A. Toth, H. Agostini, A. B. Cady, J. A. Majde, and J. M. Krueger. 1994. Comparison of acute phase responses induced in rabbits by lipopolysaccharide and double-stranded RNA. Am. J. Physiol. 267: R1596-R1605.
35. Jacobs, A. T., and L. J. Ignarro. 2001. Lipopolysaccharide-induced expression of interferon-β mediates the timing of inducible nitric-oxide synthase induction in RAW 264.7 macrophages. J. Biol. Chem. 276: 47950-47957.
36. Takeda, K., and S. Akira. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17: 1-14.
37. Yamamoto, M., S. Sato, K. Mon, K. Hoshino, O. Takeuchi, K. Takeda, and S. Akira. 2002. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the 1FN-β promoter in the Toll-like receptor signaling. J. Immunol. 169: 6668-6672.
38. Yamamoto, M., S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Sanjo, O. Takeuchi, M. Sugiyama, M. Okabe, K. Takeda, and S. Akira. 2003. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301: 640-643.
39. Oshiumi, H., M. Matsumoto, K. Funami, T. Akazawa, and T. Seya. 2003. T1-CAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction. Nat. Immunol. 4: 161-167.
40. Chan, E. D., B. W. Winston, S. T. Uh, M. W. Wynes, D. M. Rose, and D. W. Riches. 1999. Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFN-γ and TNF-α in mouse macrophages. J. Immunol. 162: 415-422.
41. Da Silva, J., B. Pierrat, J. L. Mary, and W. Lesslauer. 1997. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J. Biol. Chem. 272: 28373-28380.
42. Chae, H., J. Lee, J. Byun, W. Jung, Y. Kwak, S. Chae, and H. Kim. 2001. Blockade of p38 mitogen-activated protein kinase pathway inhibits interleukin-6 release and expression in primary neonatal cardiomyocytes. Res. Commun. Mol. Pathol. Pharmacol. 110: 209-228.
43. Badger, A. M., D. E. Griswold, R. Kapadia, S. Blake, B. A. Swift, S. J. Hoffman, G. B. Stroup, E. Webb, D. J. Rieman, M. Gowen, et al. 2000. Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis. Arthritis Rheum. 43: 175-183.
44. mapk in a mouse macrophage cell line. Am. J. Physiol. 280: C441-C450.
45. Tabeta, K., P. Georgel, E. Janssen, X. Du, K. Hoebe, K. Crozat, S. Mudd, L. Shamel, S. Sovath, J. Goode, et al. 2004. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 101: 3516-3521.
46. Chu, J. J., and M. L. Ng. 2003. The mechanism of cell death during West Nile virus infection is dependent on initial infectious dose. J. Gen. Virol. 84: 3305-3314.
47. Joseph, T., A. Cepica, L. Brown, B. O. Ikede, and F. S. Kibenge. 2004. Mechanism of cell death during infectious salmon anemia virus infection is cell type-specific. J. Gen. Virol. 85: 3027-3036.
48. Kariko, K., P. Bhuyan, J. Capodici, and D. Weissman. 2004. Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through Toll-like receptor 3. J. Immunol. 172: 6545-6549.
49. Sioud, M. 2005. Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J. Mol. Biol. 348: 1079-1090.
50. Reynolds, A., E. M. Anderson, A. Vermeulen, Y. Fedorov, K. Robinson, D. Leake, J. Karpilow, W. S. Marshall, and A. Khvorova. 2006. Induction of the interferon response by siRNA is cell type- and duplex length-dependent. RNA 12: 1-6.